Palisade Bio (PALI) Current Leases (2020 - 2025)
Palisade Bio (PALI) reported Current Leases of $24000.0 for Q2 2025, down 81.54% year-over-year from $130000.0 in Q2 2024, and down 58.62% on a QoQ basis from $58000.0 in Q1 2025.
Palisade Bio (PALI) has 6 years of Current Leases data on file, last reported at $24000.0 in Q2 2025.
- Quarterly Current Leases fell 81.54% year-over-year to $24000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $24000.0 (down 81.54% YoY) and the FY2024 annual result came in at $90000.0, down 25.62% from the prior year.
- Current Leases retreated to $24000.0 in Q2 2025 per PALI's latest filing, from $58000.0 in the prior quarter.
- Across five years, Current Leases topped out at $184000.0 in Q2 2021 and bottomed at $24000.0 in Q2 2025.
- The 5-year median for Current Leases is $112000.0 (2021), against an average of $107764.7.
- The widest annual swing landed in 2023, when Current Leases soared 67.69%; it then tumbled 81.54% in 2025.
- Tracing PALI's Current Leases over 5 years: stood at $112000.0 in 2021, then retreated by 6.25% to $105000.0 in 2022, then advanced by 15.24% to $121000.0 in 2023, then fell by 25.62% to $90000.0 in 2024, then sank by 73.33% to $24000.0 in 2025.
- Per Business Quant, the three latest PALI Current Leases figures stand at $24000.0 (Q2 2025), $58000.0 (Q1 2025), and $90000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 125,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Sep 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 98,000.00 |
| Mar 31, 2022 | 65,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 184,000.00 |
| Dec 31, 2020 | 168,000.00 |